<unk>  is an antineoplastic agent that is FDA approved for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include peripheral edema, pruritus, rash, diarrhea, loss of appetite, nausea, Vomiting,Increased liver enzymes, arthralgia, backache, myalgia, asthenia, headache, cough, dyspnea,fatigue, fever, pain, rigor..
Denileukin diftitox
Telithromycin
Cefroxadine
Doxycycline hyclate
Dapsone 
Dirithromycin
Roxithromycin
Gemifloxacin mesylate